Medical Significance of CoQ10 and Its Enhanced Production Using Potential Producer Microorganisms

Mushimiyimana Henriette; Mukama Omar; Ndikubwimana Jean De Dieu; Mukasekuru Marie Rose; Xiao-Dong Gao; Bemena Léo

doi:doi:10.11648/j.ijfsb.20170202.14

| Peer-Reviewed

Medical Significance of CoQ10 and Its Enhanced Production Using Potential Producer Microorganisms

Mushimiyimana Henriette, Mukama Omar, Ndikubwimana Jean De Dieu, Mukasekuru Marie Rose, Xiao-Dong Gao, Bemena Léo

Published in International Journal of Food Science and Biotechnology (Volume 2, Issue 2)

Received: 20 March 2017 Accepted: 27 March 2017 Published: 15 April 2017

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

Coenzyme Q10 is a polyphilic molecule resembling to vitamin structure. In the cell, CoQ10 is produced from hydrophobic isoprenoid chain conjugation with benzoquinone ring. Naturally, various ubiquinone (UQ) can be produced by yeast and microorganisms and present in human as CoQ10. It plays a critical role in human health given its use as medicine, dietary supplement and in cosmetics. Currently, CoQ10 biosynthesis is highly studied due to its critical contribution in the electron transport chain and cellular respiration which produces energy in the form of ATP. It has antioxidant activity and highly used as supplement to human with various diseases depicting high need on the market. Its high scale production is based on engineering of natural producing strains through putative techniques of metabolic engineering including mutagenesis and/or metabolic pathways modification followed by fermentation strategies optimization. Escherichia coli and Saccharomyces cerevisiae are the most used and genetically optimized. However, to date, more other strains such as Sphingomonas sp., Agrobacterium sp., and Rhodobacter sphaeroides are entirely explored with significant improvement and utility since their CoQ are similar to that produced in humans. This review will first focus on strategies used to improve CoQ10 yield with the use of preferred genetic engineering of potent strain producers and culminate with pointing out the latest medical significance of CoQ10 in light of its deficiency towards advocating its use in mitigating mitochondrial associated dysfunction, neurodegenerative and cardiovascular diseases.

Published in	International Journal of Food Science and Biotechnology (Volume 2, Issue 2)
DOI	10.11648/j.ijfsb.20170202.14
Page(s)	56-66
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2017. Published by Science Publishing Group

Keywords

CoQ10, Metabolic Engineering, Mevalonate and Non-Mevalonate Pathway, Potent, CoQ10 Producers, Medical Functions

References

[1]	Y. Wang, S. Hekimi, Molecular Genetics of Ubiquinone Biosynthesis in Animals, Critical reviews in biochemistry and molecular biology, 48 (2013) 69-88.
[2]	Y. H. Noh, K. Y. Kim, M. S. Shim, S. H. Choi, S. Choi, M. H. Ellisman, R. N. Weinreb, G. A. Perkins, W. K. Ju, Inhibition of oxidative stress by coenzyme Q10 increases mitochondrial mass and improves bioenergetic function in optic nerve head astrocytes, Cell death & disease, 4 (2013) e820.
[3]	O. S. Medvedev, L. P. Kozaeva, E. A. Gorodetskaya, E. I. Kalenikova, Intravenous administration of CoQ10 evokes increase in NO-mediated blood vessels relaxation, European journal of heart failure, 18 (2016) 426-426.
[4]	A. Sharma, G. C. Fonarow, J. Butler, J. A. Ezekowitz, G. M. Felker, Coenzyme Q10 and Heart Failure: A State-of-the-Art Review, Circulation-heart failure, 9 (2016).
[5]	R. Rodriguez-Acuna, E. Brenne, F. Lacoste, Determination of coenzyme Q10 and Q9 in vegetable oils, Journal of agricultural and food chemistry, 56 (2008) 6241-6245.
[6]	C. Venegas, C. Cabrera-Vique, L. Garcia-Corzo, G. Escames, D. Acuna-Castroviejo, L. C. Lopez, Determination of coenzyme Q10, coenzyme Q9, and melatonin contents in virgin argan oils: comparison with other edible vegetable oils, Journal of agricultural and food chemistry, 59 (2011) 12102-12108.
[7]	M. Kawamukai, Biosynthesis and bioproduction of coenzyme Q10 by yeasts and other organisms, Biotechnology and applied biochemistry, 53 (2009) 217-226.
[8]	S. Q. E. Lee, T. S. Tan, M. Kawamukai, E. S. Chen, Cellular factories for coenzyme Q10 production, Microbial cell factories, 16 (2017) 39-39.
[9]	T.-Z. Cui, M. Kawamukai, CoQ10, a mitochondrial coenzyme Q binding protein, is required for proper respiration in Schizosaccharomyces pombe, European journal of heart failure, 276 (2009) 748-759.
[10]	D. J. Pitera, C. J. Paddon, J. D. Newman, J. D. Keasling, Balancing a heterologous mevalonate pathway for improved isoprenoid production in Escherichia coli, Metabolic engineering, 9 (2007) 193-207.
[11]	J. de Dieu Ndikubwimana, B. H. Lee, Enhanced production techniques, properties and uses of coenzyme Q10, Biotechnology letters, 36 (2014) 1917-1926.
[12]	J.-K. Lee, G. Her, S.-Y. Kim, J.-H. Seo, Cloning and Functional Expression of the dps Gene Encoding Decaprenyl Diphosphate Synthase from Agrobacterium tumefaciens, Biotechnology Progress, 20 (2004) 51-56.
[13]	Y. C. Park, S. J. Kim, J. H. Choi, W. H. Lee, K. M. Park, M. Kawamukai, Y. W. Ryu, J. H. Seo, Batch and fed-batch production of coenzyme Q10 in recombinant Escherichia coli containing the decaprenyl diphosphate synthase gene from Gluconobacter suboxydans, Applied microbiology and biotechnology, 67 (2005) 192-196.
[14]	J. H. Choi, Y. W. Ryu, J. H. Seo, Biotechnological production and applications of coenzyme Q10, Applied microbiology and biotechnology, 68 (2005) 9-15.
[15]	M. V. Bule, R. S. Singhal, Combined Effect of Agitation/Aeration and Fed-Batch Strategy on Ubiquinone-10 Production by Pseudomonas diminuta, Chemical engineering and technology, 33 (2010) 885-894.
[16]	N. B. Kien, I. S. Kong, M. G. Lee, J. K. Kim, Coenzyme Q10 production in a 150-l reactor by a mutant strain of Rhodobacter sphaeroides, Journal of industrial microbiology & biotechnology, 37 (2010) 521-529.
[17]	M. C. A. C. Colussi, S. Coppola, S. Rovidati, F. Galli, L. Ghibelli, H₂O₂-induced block of glycolysis as an active ADP-ribosylation reaction protecting cells from apoptosis, Federation of american societies for experimental biology (2000).
[18]	M. Bentinger, M. Tekle, G. Dallner, Coenzyme Q – Biosynthesis and functions, Biochemical and biophysical research communications, 396 (2010) 74-79.
[19]	M. Bentinger, M. Tekle, G. Dallner, Coenzyme Q--biosynthesis and functions, Biochemical and biophysical research communications, 396 (2010) 74-79.
[20]	R. Meganathan, MenaquinoneUbiquinone Biosynthesis and Enzymology, Reference module in chemistry, Molecular sciences and chemical engineering comprehensive natural products II (2010) 411–444.
[21]	H.-W. Yen, C.-Y. Feng, J.-L. Kang, Cultivation of Rhodobacter sphaeroides in the Stirred Bioreactor with Different Feeding Strategies for CoQ10 Production, Applied biochemistry and biotechnology, 160 (2010) 1441-1449.
[22]	J. K. Lee, D. K. Oh, S. Y. Kim, Cloning and characterization of the dxs gene, encoding 1-deoxy-d-xylulose 5-phosphate synthase from Agrobacterium tumefaciens, and its overexpression in Agrobacterium tumefaciens, Journal of biotechnology, 128 (2007) 555-566.
[23]	J. D. Ndikubwimana, B. H. Lee, Enhanced production techniques, properties and uses of coenzyme Q10, Biotechnology letters, 36 (2014) 1917-1926.
[24]	J.-K. Lee, D.-K. Oh, S.-Y. Kim, Cloning and characterization of the dxs gene, encoding 1-deoxy-d-xylulose 5-phosphate synthase from Agrobacterium tumefaciens, and its overexpression in Agrobacterium tumefaciens, Journal of biotechnology, 128 (2007) 555-566.
[25]	C. A. Testa, C. Lherbet, F. Pojer, J. P. Noel, C. D. Poulter, Cloning and expression of IspDF from Mesorhizobium loti. Characterization of a bifunctional protein that catalyzes non-consecutive steps in the methylerythritol phosphate pathway, Biochimica et biophysica acta, 1764 (2006) 85-96.
[26]	M. Huang, Y. Wang, J. Liu, Z. Mao, Multiple Strategies for Metabolic Engineering of Escherichia coli for Efficient Production of Coenzyme Q10, Chinese Journal of Chemical Engineering, 19 (2011) 316-326.
[27]	C. P. Cluis, A. M. Burja, V. J. J. Martin, Current prospects for the production of coenzyme Q10 in microbes, Trends in biotechnology, 25 (2007) 514-521.
[28]	H. S. Zahiri, K. A. Noghabi, Y. C. Shin, Biochemical characterization of the decaprenyl diphosphate synthase of Rhodobacter sphaeroides for coenzyme Q10 production, Applied microbiology and biotechnology, 73 (2006) 796-806.
[29]	S.-J. Ha, S.-Y. Kim, J.-H. Seo, D.-K. Oh, J.-K. Lee, Optimization of culture conditions and scale-up to pilot and plant scales for coenzyme Q 10 production by Agrobacterium tumefaciens, Applied microbiology and biotechnology, 74 (2007) 974-980.
[30]	H. S. Zahiri, S. H. Yoon, J. D. Keasling, S. H. Lee, S. Won Kim, S. C. Yoon, Y. C. Shin, Coenzyme Q10 production in recombinant Escherichia coli strains engineered with a heterologous decaprenyl diphosphate synthase gene and foreign mevalonate pathway, Metabolic engineering, 8 (2006) 406-416.
[31]	G. H. Jung-Kul Lee, Sang-Yong Kim, and Jin-Ho Seo, Cloning and Functional Expression of the dps Gene Encoding Decaprenyl Diphosphate Synthase from Agrobacterium tumefaciens, Biotechnology progress, 20 (2004) 51−56.
[32]	Y.-J. G. Bong-Seong KOO, Sang-Yong KIM, Chan-Wha KIM, and Hyeon-Cheol LEE;, Improvement of Coenzyme Q10 Production by Increasing the NADH/NADþ Ratio in Agrobacterium tumefaciens, Biosci. Bioscience, biotechnology, and biochemistry, 74 (2014) 895–898.
[33]	C. P. Cluis, A. Ekins, L. Narcross, H. Jiang, N. D. Gold, A. M. Burja, V. J. Martin, Identification of bottlenecks in Escherichia coli engineered for the production of CoQ (10), Metabolic engineering, 13 (2011) 733-744.
[34]	Y. S. Wenqiang Lu, Shuaiwei He, Yunzhou Fei, Kai Yub, Hongwei Yu, Enhanced production of CoQ10 by constitutive overexpression of 3-demethyl ubiquinone-9 3-methyltransferase under tac promoter in Rhodobacter sphaeroides, Biochemical engineering journal 72 (2013) 42– 47.
[35]	C. L. Masters, G. Simms, N. A. Weinman, G. Multhaup, B. L. McDonald, K. Beyreuther, Amyloid plaque core protein in Alzheimer disease and Down syndrome, Proceedings of the national academy of sciences of the United States of America, 82 (1985) 4245-4249.
[36]	J. H. Choi, Y. W. Ryu, Y. C. Park, J. H. Seo, Synergistic effects of chromosomal ispB deletion and dxs overexpression on coenzyme Q (10) production in recombinant Escherichia coli expressing Agrobacterium tumefaciens dps gene, Journal of biotechnology, 144 (2009) 64-69.
[37]	L. Qiu, H. Ding, W. Wang, Z. Kong, X. Li, Y. Shi, W. Zhong, Coenzyme Q (10) production by immobilized Sphingomonas sp. ZUTE03 via a conversion-extraction coupled process in a three-phase fluidized bed reactor, Enzyme and microbial technology, 50 (2012) 137-142.
[38]	W. Zhong, W. Wang, Z. Kong, B. Wu, L. Zhong, X. Li, J. Yu, F. Zhang, Coenzyme Q (10) production directly from precursors by free and gel-entrapped Sphingomonas sp. ZUTE03 in a water-organic solvent, two-phase conversion system, Applied microbiology and biotechnology, 89 (2011) 293-302.
[39]	N. Noparatnaraporn, K. Sasaki, Y. Nishizawa, S. Nagai, Stimulation of vitamin B 12 formation in aerobically-grownRhodopseudomonas gelatinosa under microaerobic condition, Biotechnology letters, 8 (1986) 491-496.
[40]	H. W. Yen, T. Y. Shih, Coenzyme Q 10 production by Rhodobacter sphaeroides in stirred tank and in airlift bioreactor, Bioprocess and biosystems engineering, 32 (2009) 711-716.
[41]	T. Miyamae, M. Seki, T. Naga, S. Uchino, H. Asazuma, T. Yoshida, Y. Iizuka, M. Kikuchi, T. Imagawa, Y. Natsumeda, S. Yokota, Y. Yamamoto, Increased oxidative stress and coenzyme Q10 deficiency in juvenile fibromyalgia: amelioration of hypercholesterolemia and fatigue by ubiquinol-10 supplementation, Redox report: communications in free radical research, 18 (2013) 12-19.
[42]	M. V. Bule, R. S. Singhal, Combined Effect of Agitation/Aeration and Fed-Batch Strategy on Ubiquin- one-10 Production by Pseudomonas diminuta, Chemical engineering and technology, 33 (2010) 885-894.
[43]	H.-W. Yen, C.-H. Chiu, The influences of aerobic-dark and anaerobic-light cultivation on CoQ 10 production by Rhodobacter sphaeroides in the submerged fermenter, Enzyme and microbial technology, 41 (2007) 600-604.
[44]	Z. F. Wu, G. C. Du, J. Chen, Effects of culture conditions on coenzyme Q10 production by Rhizobium radiobacter by metabolic flux analysis, Acta microbiologica sinica, 45 (2005) 231-235.
[45]	Hajime Yoshida, Yukinobu Kotani, Keiko Ochiai, and Kazumi Araki, Production of ubiquinone-10 using bacteria, The journal of general and applied microbiology, 44 (1998) 19–26.
[46]	P. Tokdar, A. Sanakal, P. Ranadive, S. S. Khora, S. George, S. K. Deshmukh, Molecular, Physiological and Phenotypic Characterization of Paracoccus denitrificans ATCC 19367 Mutant Strain P-87 Producing Improved Coenzyme Q10, Indian journal of microbiology, 55 (2015) 184-193.
[47]	W. Zhong, W. Wang, Z. Kong, B. Wu, L. Zhong, X. Li, J. Yu, F. Zhang, Coenzyme Q10 production directly from precursors by free and gel-entrapped Sphingomonas sp. ZUTE03 in a water-organic solvent, two-phase conversion system, Applied microbiology and biotechnology, 89 (2011) 293-302.
[48]	C. Cluis, D. Pinel, V. Martin, The Production of Coenzyme Q10 in Microorganisms, in: X. Wang, J. Chen, P. Quinn (Eds.) Reprogramming Microbial Metabolic Pathways, Springer Netherlands 2012, pp. 303-326.
[49]	Y. Yuan, Y. Tian, T. Yue, Improvement of Coenzyme Q10 Production: Mutagenesis Induced by High Hydrostatic Pressure Treatment and Optimization of Fermentation Conditions, Journal of biomedicine and biotechnology, 2012 (2012) 607329.
[50]	D. Zhang, Z. Li, F. Wang, B. Shrestha, P. Tian, T. Tan, Expression of various genes to enhance ubiquinone metabolic pathway in Agrobacterium tumefaciens, Enzyme and microbial technology, 41 (2007) 772-779.
[51]	D. Zhang, B. Shrestha, W. Niu, P. Tian, T. Tan, Phenotypes and fed-batch fermentation of ubiquinone-overproducing fission yeast using ppt1 gene, Journal of biotechnology, 128 (2007) 120-131.
[52]	T. G. Byun, A. P. Zeng, W. D. Deckwer, Reactor comparison and scale-up for the microaerobic production of 2,3-butanediol by Enterobacter aerogenes at constant oxygen transfer rate, Bioprocess engineering, 11 (1994) 167-175.
[53]	N. Kien, I.-S. Kong, M.-G. Lee, J. Kim, Coenzyme Q10 production in a 150-l reactor by a mutant strain of Rhodobacter sphaeroides, Journal of industrial microbiology and biotechnology, 37 (2010) 521-529.
[54]	M.-J. Seo, Association of Colony Morphology with Coenzyme Q10 Production and Its Enhancement from Rhizobium radiobacter T6102W by Addition of Isopentenyl Alcohol as a Precursor, Journal of microbiology and biotechnology, 22 (2012) 230-233.
[55]	W. W. Poon, R. J. Barkovich, A. Y. Hsu, A. Frankel, P. T. Lee, J. N. Shepherd, D. C. Myles, C. F. Clarke, Yeast and rat CoQ3 and Escherichia coli UbiG polypeptides catalyze both O-methyltransferase steps in coenzyme Q biosynthesis, The journal of biological chemistry, 274 (1999) 21665-21672.
[56]	R. Alleva, M. Tomasetti, S. Bompadre, G. P. Littarru, Oxidation of LDL and their subfractions: Kinetic aspects and CoQ10 content, Molecular Aspects of Medicine, 18, Supplement 1 (1997) 105-112.
[57]	M. B. Rivara, C. K. Yeung, C. Robinson-Cohen, B. R. Phillips, J. Ruzinski, D. Rock, L. Linke, D. D. Shen, T. A. Ikizler, J. Himmelfarb, Effect of Coenzyme Q10 on Biomarkers of Oxidative Stress andCardiac Function in Hemodialysis Patients: The CoQ10 Biomarker Trial, American journal of kidney diseases: The official journal of the national kidney foundation, 69 (2017) 389-399.
[58]	N. Cornelius, J. H. Wardman, I. P. Hargreaves, V. Neergheen, A. S. Bie, Z. Tumer, J. E. Nielsen, T. T. Nielsen, Evidence of oxidative stress and mitochondrial dysfunction in spinocerebellar ataxia type 2 (SCA2) patient fibroblasts: Effect of coenzyme Q 10 supplementation on these parameters, Mitochondrion, 46 (2017) 177-183.
[59]	N. Ishii, N. Senoo-Matsuda, K. Miyake, K. Yasuda, T. Ishii, P. S. Hartman, S. Furukawa, Coenzyme Q10 can prolong C. elegans lifespan by lowering oxidative stress, Mechanisms of Ageing and Development, 125 (2004) 41-46.
[60]	R. J. B. Wayne W. Poon, Adam Y. Hsu, Adam Frankel, Peter T. Lee,, D. C. M. Jennifer N. Shepherd‡, and Catherine F. Clarke, Yeast and Rat Coq3 and Escherichia coli UbiG Polypeptides catalyze both O-Methyltransferase Steps in Coenzyme Q Biosynthesis, Journal of biological chemistry (1999) 21665-21672.
[61]	H.-C. Yen, Y.-C. Liu, C.-C. Kan, H.-J. Wei, S.-H. Lee, Y.-H. Wei, Y.-H. Feng, C.-W. Chen, C.-C. Huang, Disruption of the human COQ5-containing protein complex is associated with diminished coenzyme Q (10) levels under two different conditions of mitochondrial energy deficiency, Biochimica et biophysica acta-general subjects, 1860 (2016) 1864-1876.
[62]	K. Krumova, S. Garg, S. Dhavala, V. K. Vishnudas, M. A. Kiebish, R. Sarangarajan, N. R. Narain, Differences in dynamic modulation of CoQ10 redox status and intracellular localization between non-disease and cancer cell lines, Cancer research, 75 (2015).
[63]	N. R. Narain, L. M. Mauro, V. R. Akmaev, E. Benaim, R. Sarangarajan, J. Jimenez, Parenteral CoQ10 Formulation (BPM 31510) Significantly Improves Survival In Animal Model Of Leukemia Including The Resolution Of Paraplegia Due To Brain Metastasis, Blood, 122 (2013).
[64]	Z.-G. Zhu, M.-X. Sun, W.-L. Zhang, W.-W. Wang, Y.-M. Jin, C.-L. Xie, The efficacy and safety of coenzyme Q10 in Parkinson's disease: a meta-analysis of randomized controlled trials, Neurological sciences: official journal of the italian neurological society and of the italian society of clinical neurophysiology, 38 (2017) 215-224.
[65]	H.-N. Li, M. Zimmerman, G. Z. Milledge, X.-L. Hou, J. Cheng, Z.-H. Wang, P. A. Li, Water-Soluble Coenzyme Q 10 Reduces Rotenone-Induced Mitochondrial Fission, Neurochemical research, (2017).
[66]	K. Gumus, Topical Coenzyme Q 10 Eye Drops as an Adjuvant Treatment in Challenging Refractory Corneal Ulcers: A Case Series and Literature Review, Eye and contact lens, 43 (2017) 73-80.
[67]	P. Yu-Wai-Man, D. Soiferman, D. G. Moore, F. Burte, A. Saada, Evaluating the therapeutic potential of idebenone and related quinone analogues in Leber hereditary optic neuropathy, Mitochondrion, (2017) 1-7.
[68]	J. Garrido-Maraver, M. D. Cordero, M. Oropesa-Avila, A. F. Vega, M. de la Mata, A. D. Pavon, E. Alcocer-Gomez, C. P. Calero, M. V. Paz, M. Alanis, I. de Lavera, D. Cotan, J. A. Sanchez-Alcazar, Clinical applications of coenzyme Q 10, Frontiers in bioscience (Landmark edition), 19 (2014) 619-633.
[69]	L. Liu, K. Mao, W. T. Wang, H. C. Pan, F. Wang, M. Yang, H. Liu, Kolliphor (R) HS 15 Micelles for the Delivery of Coenzyme Q 10: Preparation, Characterization, and Stability, American association of pharmaceutical scientists, 17 (2016) 757-766.
[70]	D. Moriyama, T. Kaino, K. Yajima, R. Yanai, Y. Ikenaka, J. Hasegawa, M. Washida, H. Nanba, M. Kawamukai, Cloning and characterization of decaprenyl diphosphate synthase from three different fungi, Applied microbiology and biotechnology, 101 (2017) 1559-1571.
[71]	D. Moriyama, K. Hosono, M. Fujii, M. Washida, H. Nanba, T. Kaino, M. Kawamukai, Production of CoQ10 in fission yeast by expression of genes responsible for CoQ10 biosynthesis, Bioscience, biotechnology, and biochemistry, 79 (2015) 1026-1033.

Cite This Article

Plain Text BibTeX RIS

APA Style

Mushimiyimana Henriette, Mukama Omar, Ndikubwimana Jean De Dieu, Mukasekuru Marie Rose, Xiao-Dong Gao, et al. (2017). Medical Significance of CoQ10 and Its Enhanced Production Using Potential Producer Microorganisms. International Journal of Food Science and Biotechnology, 2(2), 56-66. https://doi.org/10.11648/j.ijfsb.20170202.14

Copy | Download

ACS Style

Mushimiyimana Henriette; Mukama Omar; Ndikubwimana Jean De Dieu; Mukasekuru Marie Rose; Xiao-Dong Gao, et al. Medical Significance of CoQ10 and Its Enhanced Production Using Potential Producer Microorganisms. Int. J. Food Sci. Biotechnol. 2017, 2(2), 56-66. doi: 10.11648/j.ijfsb.20170202.14

Copy | Download

AMA Style

Mushimiyimana Henriette, Mukama Omar, Ndikubwimana Jean De Dieu, Mukasekuru Marie Rose, Xiao-Dong Gao, et al. Medical Significance of CoQ10 and Its Enhanced Production Using Potential Producer Microorganisms. Int J Food Sci Biotechnol. 2017;2(2):56-66. doi: 10.11648/j.ijfsb.20170202.14

Copy | Download

@article{10.11648/j.ijfsb.20170202.14,
  author = {Mushimiyimana Henriette and Mukama Omar and Ndikubwimana Jean De Dieu and Mukasekuru Marie Rose and Xiao-Dong Gao and Bemena Léo},
  title = {Medical Significance of CoQ10 and Its Enhanced Production Using Potential Producer Microorganisms},
  journal = {International Journal of Food Science and Biotechnology},
  volume = {2},
  number = {2},
  pages = {56-66},
  doi = {10.11648/j.ijfsb.20170202.14},
  url = {https://doi.org/10.11648/j.ijfsb.20170202.14},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijfsb.20170202.14},
  abstract = {Coenzyme Q10 is a polyphilic molecule resembling to vitamin structure. In the cell, CoQ10 is produced from hydrophobic isoprenoid chain conjugation with benzoquinone ring. Naturally, various ubiquinone (UQ) can be produced by yeast and microorganisms and present in human as CoQ10. It plays a critical role in human health given its use as medicine, dietary supplement and in cosmetics. Currently, CoQ10 biosynthesis is highly studied due to its critical contribution in the electron transport chain and cellular respiration which produces energy in the form of ATP. It has antioxidant activity and highly used as supplement to human with various diseases depicting high need on the market. Its high scale production is based on engineering of natural producing strains through putative techniques of metabolic engineering including mutagenesis and/or metabolic pathways modification followed by fermentation strategies optimization. Escherichia coli and Saccharomyces cerevisiae are the most used and genetically optimized. However, to date, more other strains such as Sphingomonas sp., Agrobacterium sp.,  and Rhodobacter sphaeroides are entirely explored with significant improvement and utility since their CoQ are similar to that produced in humans. This review will first focus on strategies used to improve CoQ10 yield with the use of preferred genetic engineering of potent strain producers and culminate with pointing out the latest medical significance of CoQ10 in light of its deficiency towards advocating its use in mitigating mitochondrial associated dysfunction, neurodegenerative and cardiovascular diseases.},
 year = {2017}
}

Copy | Download

TY  - JOUR
T1  - Medical Significance of CoQ10 and Its Enhanced Production Using Potential Producer Microorganisms
AU  - Mushimiyimana Henriette
AU  - Mukama Omar
AU  - Ndikubwimana Jean De Dieu
AU  - Mukasekuru Marie Rose
AU  - Xiao-Dong Gao
AU  - Bemena Léo
Y1  - 2017/04/15
PY  - 2017
N1  - https://doi.org/10.11648/j.ijfsb.20170202.14
DO  - 10.11648/j.ijfsb.20170202.14
T2  - International Journal of Food Science and Biotechnology
JF  - International Journal of Food Science and Biotechnology
JO  - International Journal of Food Science and Biotechnology
SP  - 56
EP  - 66
PB  - Science Publishing Group
SN  - 2578-9643
UR  - https://doi.org/10.11648/j.ijfsb.20170202.14
AB  - Coenzyme Q10 is a polyphilic molecule resembling to vitamin structure. In the cell, CoQ10 is produced from hydrophobic isoprenoid chain conjugation with benzoquinone ring. Naturally, various ubiquinone (UQ) can be produced by yeast and microorganisms and present in human as CoQ10. It plays a critical role in human health given its use as medicine, dietary supplement and in cosmetics. Currently, CoQ10 biosynthesis is highly studied due to its critical contribution in the electron transport chain and cellular respiration which produces energy in the form of ATP. It has antioxidant activity and highly used as supplement to human with various diseases depicting high need on the market. Its high scale production is based on engineering of natural producing strains through putative techniques of metabolic engineering including mutagenesis and/or metabolic pathways modification followed by fermentation strategies optimization. Escherichia coli and Saccharomyces cerevisiae are the most used and genetically optimized. However, to date, more other strains such as Sphingomonas sp., Agrobacterium sp.,  and Rhodobacter sphaeroides are entirely explored with significant improvement and utility since their CoQ are similar to that produced in humans. This review will first focus on strategies used to improve CoQ10 yield with the use of preferred genetic engineering of potent strain producers and culminate with pointing out the latest medical significance of CoQ10 in light of its deficiency towards advocating its use in mitigating mitochondrial associated dysfunction, neurodegenerative and cardiovascular diseases.
VL  - 2
IS  - 2
ER  -

Copy | Download

Author Information

Mushimiyimana Henriette

Key Laboratory of Carbohydrate Chemistry and Biotechnology, School of Biotechnology, Jiangnan University, Wuxi, People’s Republic of China
Mukama Omar

Key Laboratory of Carbohydrate Chemistry and Biotechnology, School of Biotechnology, Jiangnan University, Wuxi, People’s Republic of China
Ndikubwimana Jean De Dieu

Key Laboratory of Carbohydrate Chemistry and Biotechnology, School of Biotechnology, Jiangnan University, Wuxi, People’s Republic of China
Mukasekuru Marie Rose

Key Laboratory of Carbohydrate Chemistry and Biotechnology, School of Biotechnology, Jiangnan University, Wuxi, People’s Republic of China
Xiao-Dong Gao

Key Laboratory of Carbohydrate Chemistry and Biotechnology, School of Biotechnology, Jiangnan University, Wuxi, People’s Republic of China
Bemena Léo

Key Laboratory of Carbohydrate Chemistry and Biotechnology, School of Biotechnology, Jiangnan University, Wuxi, People’s Republic of China

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Mushimiyimana Henriette, Mukama Omar, Ndikubwimana Jean De Dieu, Mukasekuru Marie Rose, Xiao-Dong Gao, et al. (2017). Medical Significance of CoQ10 and Its Enhanced Production Using Potential Producer Microorganisms. International Journal of Food Science and Biotechnology, 2(2), 56-66. https://doi.org/10.11648/j.ijfsb.20170202.14

Copy | Download

ACS Style

Mushimiyimana Henriette; Mukama Omar; Ndikubwimana Jean De Dieu; Mukasekuru Marie Rose; Xiao-Dong Gao, et al. Medical Significance of CoQ10 and Its Enhanced Production Using Potential Producer Microorganisms. Int. J. Food Sci. Biotechnol. 2017, 2(2), 56-66. doi: 10.11648/j.ijfsb.20170202.14

Copy | Download

AMA Style

Mushimiyimana Henriette, Mukama Omar, Ndikubwimana Jean De Dieu, Mukasekuru Marie Rose, Xiao-Dong Gao, et al. Medical Significance of CoQ10 and Its Enhanced Production Using Potential Producer Microorganisms. Int J Food Sci Biotechnol. 2017;2(2):56-66. doi: 10.11648/j.ijfsb.20170202.14

Copy | Download

@article{10.11648/j.ijfsb.20170202.14,
  author = {Mushimiyimana Henriette and Mukama Omar and Ndikubwimana Jean De Dieu and Mukasekuru Marie Rose and Xiao-Dong Gao and Bemena Léo},
  title = {Medical Significance of CoQ10 and Its Enhanced Production Using Potential Producer Microorganisms},
  journal = {International Journal of Food Science and Biotechnology},
  volume = {2},
  number = {2},
  pages = {56-66},
  doi = {10.11648/j.ijfsb.20170202.14},
  url = {https://doi.org/10.11648/j.ijfsb.20170202.14},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijfsb.20170202.14},
  abstract = {Coenzyme Q10 is a polyphilic molecule resembling to vitamin structure. In the cell, CoQ10 is produced from hydrophobic isoprenoid chain conjugation with benzoquinone ring. Naturally, various ubiquinone (UQ) can be produced by yeast and microorganisms and present in human as CoQ10. It plays a critical role in human health given its use as medicine, dietary supplement and in cosmetics. Currently, CoQ10 biosynthesis is highly studied due to its critical contribution in the electron transport chain and cellular respiration which produces energy in the form of ATP. It has antioxidant activity and highly used as supplement to human with various diseases depicting high need on the market. Its high scale production is based on engineering of natural producing strains through putative techniques of metabolic engineering including mutagenesis and/or metabolic pathways modification followed by fermentation strategies optimization. Escherichia coli and Saccharomyces cerevisiae are the most used and genetically optimized. However, to date, more other strains such as Sphingomonas sp., Agrobacterium sp.,  and Rhodobacter sphaeroides are entirely explored with significant improvement and utility since their CoQ are similar to that produced in humans. This review will first focus on strategies used to improve CoQ10 yield with the use of preferred genetic engineering of potent strain producers and culminate with pointing out the latest medical significance of CoQ10 in light of its deficiency towards advocating its use in mitigating mitochondrial associated dysfunction, neurodegenerative and cardiovascular diseases.},
 year = {2017}
}

Copy | Download

TY  - JOUR
T1  - Medical Significance of CoQ10 and Its Enhanced Production Using Potential Producer Microorganisms
AU  - Mushimiyimana Henriette
AU  - Mukama Omar
AU  - Ndikubwimana Jean De Dieu
AU  - Mukasekuru Marie Rose
AU  - Xiao-Dong Gao
AU  - Bemena Léo
Y1  - 2017/04/15
PY  - 2017
N1  - https://doi.org/10.11648/j.ijfsb.20170202.14
DO  - 10.11648/j.ijfsb.20170202.14
T2  - International Journal of Food Science and Biotechnology
JF  - International Journal of Food Science and Biotechnology
JO  - International Journal of Food Science and Biotechnology
SP  - 56
EP  - 66
PB  - Science Publishing Group
SN  - 2578-9643
UR  - https://doi.org/10.11648/j.ijfsb.20170202.14
AB  - Coenzyme Q10 is a polyphilic molecule resembling to vitamin structure. In the cell, CoQ10 is produced from hydrophobic isoprenoid chain conjugation with benzoquinone ring. Naturally, various ubiquinone (UQ) can be produced by yeast and microorganisms and present in human as CoQ10. It plays a critical role in human health given its use as medicine, dietary supplement and in cosmetics. Currently, CoQ10 biosynthesis is highly studied due to its critical contribution in the electron transport chain and cellular respiration which produces energy in the form of ATP. It has antioxidant activity and highly used as supplement to human with various diseases depicting high need on the market. Its high scale production is based on engineering of natural producing strains through putative techniques of metabolic engineering including mutagenesis and/or metabolic pathways modification followed by fermentation strategies optimization. Escherichia coli and Saccharomyces cerevisiae are the most used and genetically optimized. However, to date, more other strains such as Sphingomonas sp., Agrobacterium sp.,  and Rhodobacter sphaeroides are entirely explored with significant improvement and utility since their CoQ are similar to that produced in humans. This review will first focus on strategies used to improve CoQ10 yield with the use of preferred genetic engineering of potent strain producers and culminate with pointing out the latest medical significance of CoQ10 in light of its deficiency towards advocating its use in mitigating mitochondrial associated dysfunction, neurodegenerative and cardiovascular diseases.
VL  - 2
IS  - 2
ER  -

Copy | Download